Bowling Portfolio Management LLC Ligand Pharmaceuticals Inc Transaction History

Bowling Portfolio Management LLC

  • $364 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 18, 2018
SELL
$211.18 - $274.49 $1.07 Million - $1.39 Million
-5,047 Closed
0 $0
Q2 2018

Aug 06, 2018
BUY
$150.77 - $207.98 $278,773 - $384,555
1,849 Added 57.82%
5,047 $1.05 Million
Q1 2018

Apr 25, 2018
SELL
$138.63 - $182.62 $17,467 - $23,010
-126 Reduced 3.79%
3,198 $528,000
Q4 2017

Jan 22, 2018
BUY
$128.36 - $147.04 $426,668 - $488,760
3,324
3,324 $455,000

Others Institutions Holding LGND

# of Institutions
255
Shares Held
18.1M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.86B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Bowling Portfolio Management LLC Portfolio

Follow Bowling Portfolio Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowling Portfolio Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bowling Portfolio Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email